External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Oncology USCAP 2024
Roche and Genentech at

USCAP 2024

March 23 - March 28
Baltimore, Maryland
uscap.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon

Sign up or login to unlock the full suite of MEDICALLY features
Personalised Healthcare
Mar 27 / Roche
Testing and Interpretation of HER2 Protein Expression and Gene Amplification in Urothelial Carcinoma
We report preliminary results from an ongoing evaluation of HER2 protein expression and gene amplification in la/mUC using optimized, UC-specific immunohistochemistry (IHC) and gene amplification in situ hybridization (ISH) assays.
Oncology Gastrointestinal Cancer Digital Pathology USCAP-2024
09:30 PM
Duration 150mins Baltimore, Maryland
Testing and Interpretation of HER2 Protein Expression and Gene Amplification in Urothelial Carcinoma
Emily Chan
Oncology | Gastrointestinal Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.